8Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999 [J]. MMWR Morb Mortal Wkly Rep, 1999,48 ( 32 ) :707-710.
9Klevens RM, Morrison MA, Nadle J, el al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States[J]. JAMA ,2007,298( 15 ):1763-1771.
10Gorwitz R J, Jernigan DB, Powers JH, et el. Strategies for clinical management of MRSA in the community: summary of an experts' meeting convened by the Centers for Disease Control and Prevention [J/OL]. 2006. Available at http://www.cdc.gov/ncidod/ dhqp/ar_mrsa_ca.html.
9LEE P,DIPERSIO D,JEROME R N,et al. Approaching andanalyzing a large literature on vancomycin monitoring andpharmacokinetics[J]. J Med Libr Assec,2007,95(4):374-379.
10NAKAYAMA H,ECHIZEN H,TANAKA M,et al. Reducedvancomycin clearance despite unchanged creatinine clearancein patients treared with vancomycin for longer than 4 weeks[J]. Ther Drug Monit,2008,30(1):103-107.
